机译:FcyRIII与缺乏核心岩藻糖的抗体之间的高亲和力结合需要独特的碳水化合物-碳水化合物相互作用
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;
Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;
immunoglobulin; afucosylation; antibody effector function; x-ray crystallography;
机译:对岩藻糖阴性抗体FcgammaRIIIa的增强结合亲和力足以诱导最大的抗体依赖性细胞毒性。
机译:在抗体的核心岩藻糖上的位点选择化学酶改性增强了其Fcγ受体亲和力和ADCC活性
机译:使用额叶亲和色谱法对尖角豆和豌豆核心岩藻糖结合凝集素的比较分析。
机译:磁性纳米粒子对抗体 - 抗原相互作用的结合亲和力/耐酸性的影响
机译:合成抗体工程:i)靶向聚糖; ii)高亲和力与HIV-1 5-螺旋结合所需的D5变体的特征
机译:FcγRIII与缺乏核心岩藻糖的抗体之间的高亲和力结合需要独特的碳水化合物与碳水化合物相互作用
机译:FcγRIII与缺乏核心岩藻糖的抗体之间的高亲和力结合需要独特的碳水化合物与碳水化合物相互作用
机译:使用BIacore测定溶组织内阿米巴半乳糖粘附凝集素补体 - 裂解增强单克隆抗体3D12的独特表位结合位点